Medech life scientists Medicch Caris finds to raise $ 423.5 million in IPO

The company cares for technology users to help the diagnose in diagnosis and treatment of cancer, is looking for an important retail offer.

The company’s planning company in the 6th street .5 million shares at $ 23.5 million for the US Commission to the United States. Neuberger shows that it will be interested in buying as many offerings as much as 75 million dollars at IPO, filing documents.

At the top of the level, the company will have a market value $ 5.35 billion, according to Bloomberg calculation.

Related:Department of Life Next Hub? What a quarter of Texas research means for plano

Caris has a net prize of $ 120 million for the first $ 32.1 million in $ 80.7 million in $ 80.7 million at the same time.

Set up in 2008, Caris use wisdom and artificial machine learning to analyze information on oncology and monitoring of the submission, displaying submission. The company conducted more than 6.5 million cases of work more than 849,000 cases. Its product products consist of Mi profile, with molecular profile of the brain, which creates most of the caris; And guarantee Caris, a Blood molecular solution in the first quarter of 2024.

Health care and technology, usually sales in 2025.

The founder and President David David David Halbert is expected to be useful to 41.7% after the display of display. Street Street Stret Stirt Stirt Melballs is scheduled to be available to 9.8.8%.

Last year, which has shown a health care capacity

The offering is led by Bank of America Corp., JPMorgan Chase & CO. , Goldman Sachs Group Inc and Citigroup Inc. And Citigroup Inc. The company planned for its share of trading in Nasdaq worlds market under symbols.

– Hughes Anthony for Bloomberg